未登录

A

André De Souza

lifespan health rhode island

H指数:11

被引数:463

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Brazilian external quality assessment program for serum TSH and free T4-A report from 2007 to 2023

CLINICA CHIMICA ACTA

IF2.9

2024-05-010

PRE

Patient-derived MTAP-deleted bladder cancer organoid model: A unique platform for drug development

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Androgen deprivation therapy (ADT) and senescence-associated secretory phenotype (SASP) in vitro: Correlation with SASP in tumor specimens as well as in the serum of patients after ADT

CANCER RESEARCH

IF16.6

2024-03-220

PRE

An analysis of proviral insertion site of Moloney murine leukemia virus, PIM1, kinase expression and clinical outcomes in renal cell carcinoma

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Reply to the comments on Souza et al. (2022) Recent geomorphological changes in the Paraiba do Sul delta, South America East Coast

对Souza等人的评论的答复。(2022) 南美东海岸南帕拉伊巴三角洲最近的地貌变化

PROGRESS IN PHYSICAL GEOGRAPHY-EARTH AND ENVIRONMENT

IF3.6

2023-07-152

PRE

BrUOG360: A phase Ib/II study of copanlisib combined with rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC)

CANCER RESEARCH

IF16.6

2023-04-140

PRE

Androgen signaling blockade enhances NK cell-mediated killing of prostate cancer cells (PC) and promotes NK cell tumor infiltration in vivo

CANCER RESEARCH

IF16.6

2023-04-040

PRE

IFN-γ and TRAIL involvement in androgen signaling-mediated NK cell killing of prostate cancer cells and further enhancement by NKG2A checkpoint inhibition with monalizumab

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Genesis and Distribution of Low Fluvial Terraces Formed by Holocene Climate Pulses in Brazil

IF3

2022-09-228

OA

Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma

CANCER BIOLOGY & THERAPY

IF4.6

2022-07-0913

OAAI

Recent geomorphological changes in the Paraiba do Sul delta, South America East Coast

PROGRESS IN PHYSICAL GEOGRAPHY-EARTH AND ENVIRONMENT

IF3.6

2022-04-1010

PRE

Genomic biomarkers for response to 9-ING-41, a small molecule selective glycogen synthase kinase-3 (GSK-3) inhibitor, in pancreas cancer: Preliminary results

MOLECULAR CANCER THERAPEUTICS

IF5.5

2021-12-010

PRE

Differential transcriptomic profiling of BCL2-related genes in primary tumor (PT) and metastatic sites (MS) of prostate cancer (PCa)

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

OA

p53 Expression, Programmed Death Ligand 1, and Risk Factors in Urinary Tract Small Cell Carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2021-04-220

OAAI

Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner

JOURNAL OF EXTRACELLULAR VESICLES

IF14.5

2020-12-3157

OA

Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-10-192

OAAI

Glycogen synthase kinase 3-β expression in prostate cancer (PCa) correlates with aggressive pathological features and its blockade with 9-ING-41 inhibits viability of PCa cell lines

CANCER RESEARCH

IF16.6

2020-08-151

PRE

ONC201 shows synergistic effect with the androgen receptor AR-inhibitor darotulamide in prostate cancer models

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses

CANCER BIOLOGY & THERAPY

IF4.6

2019-04-1271

OAAI